We have democratized access to continuous glucose monitors so that people can actually understand their own metabolic health because it's the most important aspect of our health. And Right now that technology [continuous glucose monitors] has been actually by the healthcare system, been sequestered just to people who already have type 2 diabetes. And the vision of the company is to help people before they get these diseases, to understand how their diet and their lifestyle are affecting their metabolic health by using these totally available, not very expensive sensors and pairing it with intelligent software. (2:21:03–2:21:11)
CLAIM
Asserts that continuous glucose monitors are currently restricted by the healthcare system to people with type 2 diabetes.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
